Deutsche Bank
MLYS icon

Deutsche Bank’s Mineralys Therapeutics MLYS Stock Holding History

Deutsche Bank’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.44M Sell
57,392
-1,485
-3% -$40.4K ﹤0.01% 1985
2026
Q2 		$1.59M Buy
58,877
+18,761
+47% +$515K ﹤0.01% 2043
2026
Q1 		$1.09M Buy
40,116
+2,871
+8% +$84.2K ﹤0.01% 2134
2025
Q4 		$1.35M Buy
37,245
+6,315
+20% +$253K ﹤0.01% 2031
2025
Q3 		$1.17M Sell
30,930
-425,984
-93% -$9.21M ﹤0.01% 2074
2025
Q2 		$6.18M Buy
456,914
+160,899
+54% +$2.33M ﹤0.01% 1157
2025
Q1 		$4.7M Buy
296,015
+269,283
+1,007% +$3.1M ﹤0.01% 1276
2024
Q4 		$329K Buy
26,732
+10,264
+62% +$134K ﹤0.01% 2851
2024
Q3 		$199K Buy
16,468
+4,836
+42% +$58.5K ﹤0.01% 2926
2024
Q2 		$136K Buy
11,632
+3,299
+40% +$41.6K ﹤0.01% 3009
2024
Q1 		$108K Buy
+8,333
New +$103K ﹤0.01% 3136
2023
Q4 		– Sell
-5,678
Closed -$54K – 3675
2023
Q3 		$54K Hold
5,678
– – ﹤0.01% 3394
2023
Q2 		$96.8K Sell
5,678
-1,827
-24% -$27.3K ﹤0.01% 3288
2023
Q1 		$118K Buy
+7,505
New +$126K ﹤0.01% 3255

Other funds holding MLYS

Catalys Pacific
Catalys Pacific Tokyo, Japan $210M AUM 33.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Andera Partners
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Deutsche Bank's MLYS Position: Q3 2026 in Review

Deutsche Bank reduced its Mineralys Therapeutics (MLYS) stake by 2.5% in Q3 2026, selling an estimated $40.4K and leaving 57,392 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1985.

Deutsche Bank first reported a position in MLYS in Q1 2023 and has held it in 14 quarters since. The position peaked at $6.18M in Q2 2025. 88 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.

  • Deutsche Bank held 57,392 shares of Mineralys Therapeutics worth $1.44M as of Q3 2026.
  • Deutsche Bank sold 1,485 Mineralys Therapeutics shares in Q3 2026, an estimated $40.4K.
  • Mineralys Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #1985 holding.
  • Deutsche Bank first reported a position in Mineralys Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • Deutsche Bank's Mineralys Therapeutics position peaked at $6.18M in Q2 2025.
  • 88 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.